Sign in

Jennifer Taubert

Director at MCDONALDSMCDONALDS
Board

About Jennifer Taubert

Jennifer Taubert (age 61) is Executive Vice President and Worldwide Chairman, Innovative Medicine at Johnson & Johnson and has served on McDonald’s Board for 2 years. Her background includes senior leadership of a global pharmaceuticals division and membership on J&J’s executive committee, bringing regulatory/public policy and human capital management expertise to McDonald’s governance. She is currently an independent director at McDonald’s, not serving as a committee chair.

Past Roles

OrganizationRoleTenureCommittees/Impact
Johnson & JohnsonEVP & Worldwide Chairman, Innovative Medicine2018–PresentExecutive committee member; extensive regulatory/public policy and HCM experience
Johnson & JohnsonCompany Group Chairman, The Americas, Pharmaceuticals2015–2018Led pharmaceuticals across the Americas
Johnson & JohnsonCompany Group Chairman, North America, Pharmaceuticals2012–2015Led North America pharmaceuticals

External Roles

OrganizationRoleTenureCommittees/Impact
McDonald’s discloses no other current public company boards for Taubert

Board Governance

  • Committee memberships: Audit & Finance; Compensation. Not a committee chair. Audit & Finance met 8 times in 2024; Compensation met 4 times in 2024.
  • Independence: Board determined all non‑management directors, including Taubert, are independent under NYSE standards and McDonald’s policies.
  • Attendance: In 2024, the Board met 7 times; directors attended on average 96% of Board/committee meetings (each ≥75% attendance).
  • Executive sessions: Independent directors meet regularly; Chairman presides except on leadership/compensation matters, when the Lead Independent Director presides.
  • Outside board service policy: Directors may serve on no more than three other public company boards (in addition to MCD); prior notice/consent required, with resignation offer if notice not provided.

Fixed Compensation

ComponentProgram TermsTaubert 2024 Amount ($)
Annual cash retainer$120,000 cash retainer for directors120,000
Equity (stock equivalent units)Annual grant under Directors’ Plan; $205,000 value in 2024; credited at closing price; settled in cash after board service203,060 (grant date fair value)
Committee chair fees$30,000 (Audit & Finance Chair); $25,000 (Compensation, Governance, Corporate Responsibility Chairs)N/A (not a chair)
Lead Independent Director premiumAdditional $50,000 cash retainer (Miles White in 2024)N/A
Charitable matchUp to $10,000 matched annually10,000
Total (2024)333,060

Notes:

  • Directors may elect to defer retainers into stock equivalent units; units are payable in cash post‑service with lump sum or installments up to 15 years.
  • Directors’ equity awards are common stock equivalent units, not actual shares.

Performance Compensation

  • McDonald’s does not disclose performance‑contingent elements for director compensation; director equity is granted as stock equivalent units without performance metrics.

Other Directorships & Interlocks

CompanyRelationship to MCDNotes
NoneMcDonald’s lists zero other public company boards for Taubert; Board independence review considers any commercial relationships at employers and found none impairing independence.

Expertise & Qualifications

  • Senior executive experience in global, complex organizations; regulatory/public policy; human capital management; inclusion leadership; management/marketing/finance/business development/global operations (J&J).
  • Contribution to Board skill matrix includes brand management, customer‑centricity, finance/capital markets, global experience, HCM, IT/cyber, marketing, sustainability/corporate responsibility.

Equity Ownership

As of March 1, 2025Common Stock (shares)Stock Equivalents (units)Total
Jennifer Taubert0 2,565 2,565
  • Director ownership guidelines: Directors should own shares equal to 5x annual cash retainer within 5 years; McDonald’s states all directors are currently in compliance and prohibits hedging/pledging.
  • Observation: Taubert held no direct common shares as of March 1, 2025; holdings consist of cash‑settled stock equivalents under the Directors’ Plan.

Insider Filings

Filing DateFormKey Detail
2022-10-07Form 3Initial statement of beneficial ownership; “No securities are beneficially owned.”

Related Party Transactions and Conflicts

  • Policy: Board reviews/ratifies related person transactions; pre‑approves certain categories; directors must report conflicts; annual review performed.
  • Disclosure: Since Jan 1, 2023, no related person transactions >$120,000 in which a related person had a direct/indirect material interest.
  • Independence review: Board considered commercial relationships with companies where directors are employees; transactions were arm’s‑length and did not affect independence; all non‑management directors deemed independent.

Shareholder Engagement and Say‑on‑Pay Context

  • Engagement: Since last meeting, outreach to shareholders representing ~43% of outstanding shares; independent directors participate.
  • Executive pay governance: Robust pay‑for‑performance design for executives; not directly applicable to director pay.

Governance Assessment

  • Strengths: Independent status; service on key oversight committees (Audit & Finance; Compensation); Board reports strong overall attendance; robust related‑party and independence reviews; restrictions on outside boards and anti‑hedging/pledging policies.
  • Alignment considerations: As of March 1, 2025, Taubert held zero direct common shares and only cash‑settled stock equivalents, which may provide less direct “skin‑in‑the‑game” alignment versus owning shares; however, McDonald’s states all directors comply with ownership guidelines and director equity awards track McDonald’s stock performance.
  • Conflicts: Executive role at J&J could be a theoretical interlock if commercial ties existed; Board’s annual independence review concluded arm’s‑length relationships and maintained independence; no related‑party transactions reported.

RED FLAGS

  • Zero direct share ownership as of March 1, 2025 (ownership solely via cash‑settled stock equivalents). Monitoring for progress toward share ownership guideline compliance is prudent.